Exchange
—
Entity type
operating
Fiscal year end
Nov 30
Headquarters
MI
Company overview
Somanetics Corp., operating within the Electromedical & Electrotherapeutic Apparatus SIC backdrop, specializes in portable, non-invasive cerebral and somatic oximetry systems that deliver continuous regional oxygen saturation data during surgery and critical care, with core products tailored for cardiovascular surgeons, anesthesiologists, and perioperative teams in hospitals and surgical centers seeking better neuromonitoring clarity; the company also supports rehabilitation clinics with monitoring accessories. CIK 704328 remains the anchor for compliance, and the latest Form 10-Q filed in September 1999 reiterates the heavy regulatory oversight from the FDA and CMS reimbursement scrutiny that could materially affect product rollouts, pricing, and adoption, especially given the capital-intensive nature of clinical procurement and the need to prove long-term value in a cautious capital market. Investors should weigh those risks along with the company’s efforts to expand clinical training and integration with EMRs. View live SEC filings on Earnings Feed.
Source: Earnings Feed research · last updated 11/24/2025
Recent filings
- SOMANETICS CORP61.8 KB
SOMANETICS CORP 10-Q
- SOMANETICS CORP78.8 KB
SOMANETICS CORP 10-Q
- SOMANETICS CORP51.5 KB
SOMANETICS CORP 10-Q
- SOMANETICS CORP81.9 KB
SOMANETICS CORP 10-Q
- SOMANETICS CORP59.5 KB
SOMANETICS CORP 10-Q